Clinical assessment of suicide risk in depressive disorder

CNS Spectrums

Volumn 11, Issue 6, 2006, Pages 455-461

  Coryell, William H ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CHOLESTEROL; DEXAMETHASONE; FENFLURAMINE; SEROTONIN;

AGGRESSION; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FOLLOW UP; HOPELESSNESS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMPULSIVENESS; LONELINESS; MENTAL DISEASE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SUICIDAL BEHAVIOR; SUICIDE;

EID: 33745304379     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285290001467X     Document Type: Review

References (84)

1. Busch KA, Fawcett J, Jacobs DG. Clinical correlates of inpatient suicide. J Clin Psychiatry. 2003;64:14-19.
2. Isacsson G, Bergman U, Rich CL. Antidepressants, depression and suicide: an analysis of the San Diego study. J Affect Disord. 1994;32:277-286.
3. Murphy GE, Wetzel RD, Robins E, McEvoy L. Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry. 1992;49:459-463.
4. Young EA, Coryell W. Suicide and the hypothalamic-pituitary-adrenal axis. Lancet. 2005;366:959-961.
5. Beck AT, Hermann I, Schuyler D. Development of suicide intent scores. In: Beck AT, Resnick HLP, Lettieri DJ, eds. The Prediction of Suicide. Bowes, Md: Charles Press; 1974:45-56.
6. Hjelmeland H, Stiles TC, Bille-Brahe U, Ostamo A, Salender-Renberg E, Wasserman D. The value of suicide intent and various motives as predictors for future suicidal behavior. Arch Suicide Res. 1998;4:209-225.
7. Harriss L, Hawton K. Suicidal intent in deliberate self-harm and the risk of suicide: the predictive power of the Suicide Intent Scale. J Affect Disord. 2005;86:225-233.
8. Nimeus A, Alsen M, Traskman-Bendz L. High suicidal intent scores indicate future suicide. Arch Suicide Res. 2002;6:211-219.
9. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia. New York, NY: New York State Psychiatric Institute; 1978.
10. Coryell W, Young EA. Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiatry. 2005;66:412-417.
11. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002;68:167-181.
12. Barraclough BM, Pallis DJ. Depression followed by suicide: a comparison of depressed suicides with living depressives. Psychol Med. 1975;5:55-61.
13. Bradvik L, Berglund M. Risk factors for suicide in melancholia. A case-record evaluation of 89 suicides and their controls. Acta Psychiatr Scand. 1993;87:303-311.
14. Bradvik L, Berglund M. Late mortality in severe depression. Acta Psychiatr Scand. 2001;103:111-116.
15. Fawcett J, Scheftner W, Clark D, Hedeker D, Gibbons R, Coryell W. Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am J Psychiatry. 1987;144:35-40.
16. Fawcett J, Scheftner WA, Fogg L, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147:1189-1194.
17. Maser JD, Akiskal HS, Schlettier P, et al. Can temperament identify affectively ill patients who complete or seriously attempt suicide? A fourteen year prospective study. Suicide Life Threat Behav. 2002;32:10-32.
18. Fowler RC, Tsuang MT, Kronfol Z. Communication of suicidal intent and suicide in unipolar depression. A forty year follow-up. J Affect Disord. 1979;1:219-225.
19. Goldstein RB, Black DW, Nasrallah A, Winokur G. The prediction of suicide, Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Arch Gen Psychiatry. 1991;48:418-422.
20. Modestin J, Kopp W. A study of clinical suicide. J Nerv Ment Dis. 1983;176:668-674.
21. Nordstrom P, Asberg M, Aberg-Wistedt A, Nordin C. Attempted suicide predicts suicide risk in mood disorders. Acta Psychiatr Scand. 1995;92:345-350.
22. Roy A. Suicide in depressives. Compr Psychiatry. 1983;24:487-491.
23. Schneider B, Philipp M, Muller MJ. Psychopathological predictors of suicide in patients with major depression during a 5-year follow-up. Eur Psychiatry. 2001;16:283-288.
24. Sinclair JM, Harriss L, Baldwin DS, King EA. Suicide in depressive disorders: a retrospective case-control study of 127 suicides. J Affect Disord. 2005;87:107-113.
25. Hoyer EH, Olesen AV, Mortensen PB. Suicide risk in patients hospitalised because of an affective disorder: a follow-up study, 1973-1993. J Affect Disord. 2004;78:209-217.
26. Kessing LV. Subtypes of depressive episodes according to ICD-10: prediction of risk of relapse and suicide. Psychopathology. 2003;36:285-291.
27. Newman SC, Bland RC. Suicide risk varies by subtype of affective disorder. Acta Psychiatr Scand. 1991;83:420-426.
28. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701-709.
29. Gladstone GL, Mitchell PB, Parker G, Wilhelm K, Austin MP, Eyers K. Indicators of suicide over ten years in a specialist mood disorders unit sample. J Clin Psychiatry. 2001;62:945-951.
30. Dorovini-Zis K, Zis AP. Increased adrenal weight in victims of violent suicide. Am J Psychiatry. 1987;144:1214-1215.
31. Szigethy E, Conwell Y, Forbes NT, Cox C, Caine ED. Adrenal weight and morphology in victims of completed suicide. Biol Psychiatry. 1994;36:374-380.
32. Dumser T, Barocka A, Schubert E. Weight of adrenal glands may be increased in persons who commit suicide. Am J Forensic Med Pathol. 1998;19:72-76.
33. Nemeroff CB, Krishnan RR, Reed D, Leder R, Beam C, Dunnick NR. Adrenal gland enlargement in major depression; a computed tomographic study. Arch Gen Psychiatry. 1992;49:384-387.
34. Arato M, Banki CM, Bissette G, Nemeroff CB. Elevated CSF CRF in suicide victims. Biol Psychiatry. 1989;25:355-359.
35. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased rumbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 1994;60:433-444.
36. Lopez JF, Palkovits M, Arato M, Mansour A, Akil H, Watson SJ. Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology. 1992;56:491-501.
37. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry. 1988;45:577-579.
38. Black DW, Monahan PD, Winokur G. The relationship between DST results and suicidal behavior. Ann Clin Psychiatry. 2002;14:83-88.
39. Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry. 2001;158:748-753.
40. Coryell W, Young E, Carroll B. HPA-axis hyperactivity in mortality in major depressive disorder. Psychiatry Res. In press.
41. Coryell W, Schlesser M. Combined biological tests for suicide prediction. Psychiatry Res. In press.
42. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology. 2001;24:467-477.
43. Stanley B, Molcho A, Stanley M, et al. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry. 2000;157:609-614.
44. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry. 1997;154:1430-1435.
45. Michaelis BH, Goldberg JF, Davis GP, Singer TM, Garno JL, Wenze SJ. Dimensions of impulsivity and aggression associated with suicide attempts among bipolar patients: a preliminary study. Suicide Life Threat Behav. 2004;34:172-176.
46. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Steinberg JL, Moeller FG. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry. 2005;162:1680-1687.
47. Dumais A, Lesage AD, Lalovic A, et al. Is violent method of suicide a behavioral marker of lifetime aggression? Am J Psychiatry. 2005;162:1375-1378.
48. Delva NJ, Matthews DR, Cowen PJ: Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs. Biol Psychiatry. 1996;39:100-106.
49. Steegmans PH, Fekkes D, Hoes AW, Bak AA, van der Does E, Grobbee DE. Low serum cholesterol concentration and serotonin metabolism in men. BMJ. 1996;312:221.
50. Terao T, Yoshimura R, Ohmori O, et al. Effect of serum cholesterol levels on metachlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects. Biol Psychiatry. 1997;41:974-978.
51. Vevera J, Fisar Z, Kvasnicka T, et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res. 2005;133:197-203.
52. Muldoon MF, Kaplan JR, Manuck SB, Mann JJ. Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol Psychiatry. 1992;31:739-742.
53. Kaplan JR, Shively CA, Fontenot MB, et al. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom Med. 1994;56:479-484.
54. Ormiston T, Wolkowitz OM, Reus VI, Manfredi F. Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics. 2003;44:412-414.
55. Garland M, Hickey D, Corvin A, et al. Total serum cholesterol in relation to psychological correlates in parasuicide. Br J Psychiatry. 2000;177:77-83.
56. Guillem E, Pelissolo A, Notides C, Lepine JP. Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients. Psychiatry Res. 2002;112:83-88.
57. Kunugi H, Takei N, Aoki H, Nanko S. Low serum cholesterol in suicide attempters. Biol Psychiatry. 1997;41:196-200.
58. Papassotiropoulos A, Hawellek B, Frahnert C, Rao GS, Rao ML. The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry. 1999;32:1-4.
59. Gallerani M, Manfredini R, Caracciolo S, Scapoli C, Molinari S, Fersini C. Serum cholesterol concentrations in parasuicide. BMJ. 1995;310:1632-1636.
60. Sarchiapone M, Roy A, Camardese G, De Risio S. Further evidence for low serum cholesterol and suicidal behaviour. J Affect Disord 2000;61:69-71.
61. Tripodianakis J, Markianos M, Sarantidis D, Agouridaki M. Biogenic amine turnover and serum cholesterol in suicide attempt. Eur Arch Psychiatry Clin Neurosci. 2002;252:38-43.
62. Alvarez JC, Cremniter D, Lesieur P, et al. Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol Psychiatry. 1999;45:1066-1069.
63. Kim YK, Myint AM. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord. 2004;81:161-166.
64. Modai I, Valevski A, Dror S, Weizman A. Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. J Clin Psychiatry. 1994;55:252-254.
65. Bocchetta A, Chillotti C, Carboni G, Oi A, Ponti M, Del Zompo M. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatr Scand. 2001;104:37-41.
66. Ozer OA, Kutanis R, Agargun MY, et al. Serum lipid levels, suicidality, and panic disorder. Compr Psychiatry. 2004;45:95-98.
67. Atmaca M, Kuloglu M, Tezcan E, Semercioz A. The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int J Impot Res. 2002;14:502-505.
68. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scand. 2003;108:208-214.
69. Favaro A, Caregaro L, Di Pascoli L, Brambilla F, Santonastaso P. Total serum cholesterol and suicidality in anorexia nervosa. Psychosom Med. 2004;66:548-552.
70. Alvarez JC, Cremniter D, Gluck N, et al. Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res. 2000;95:103-108.
71. Ellison LF, Morrison HI. Low serum cholesterol concentration and risk of suicide. Epidemiology. 2001;12:168-172.
72. Lindberg G, Rastam L, Gullberg B, Eklund GA. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ. 1992;305:277-279.
73. Zureik M, Courbon D, Ducimetiere P. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. BMJ. 1996;313:649-651.
74. Carroll BJ, Greden JF, Feinberg M. Suicide, neuroendocrine dysfunction and CSF 5-HIAA concentrations in depression. In: Angrist B, ed. Recent Advances in Neuropsychopharmacology: Proceedings of 12th CINP Congress. Oxford, England: Pergoman Press; 1980:307-313.
75. Roy A, Jimerson DC, Pickar D. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test. Am J Psychiatry. 1986;143:846-851.
76. Boza RA, Milanes FJ, Llorente M, Reisch J, Slater VL, Garrigo L. The DST and suicide among depressed alcoholic patients. Am J Psychiatry. 1988;145:266-267.
77. Coryell W, Schlesser MA. Suicide and the dexamethasone suppression test in unipolar depression. Am J Psychiatry. 1981;138:1120-1121.
78. Yerevanian BI, Feusner JD, Koek RJ, Mintz J. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord. 2004;83:103-108.
79. Norman WH, Brown WA, Miller IW, Keitner GI, Overholser JC. The dexamethasone suppression test and completed suicide. Acta Psychiatr Scand. 1990;81:120-125.
80. Nielsen J, Bostwick JM. The dexamethasone suppression test as a predictor of suicide risk. Mayo Clin Proc. In press.
81. Fawcett J, Busch KA, Jacobs D, Kravitz HM, Fogg L. Suicide: a four-pathway clinical-biochemical model. Ann N Y Acad Sci. 1997;836:288-301.
82. Zimmerman M, Coryell W, Pfohl B, Stangl D. An American validation study of the Newcastle Diagnostic Scale. II. Relationship with clinical, demographic, familial and psychosocial features. Br J Psychiatry. 1987;150:526-532.
83. Oquendo MA, Russo SA, Underwood MD, et al. Higher postmortem prefrontal 5-HT(2A) receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry. 2006;59:235-243.
84. Dougherty DM, Mathias CW, Marsh DM, Papageorgiou TD, Swann AC, Moeller FG. Laboratory measured behavioral impulsivity relates to suicide attempt history. Suicide Life Threat Behav. 2004;34:374-385.